Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 vs Sildenafil in Fetal Growth Restriction
NCT06565728Phase 1Completed
- Sponsor
- Cairo University
- Start
- Nov 2022
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised trial of cholecalciferol and ASP-001 in fetal growth restriction (FGR), sponsored by Cairo University. Started Nov 2022; status: completed.
02
Drugs
cholecalciferolASP-001
03
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT06565728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06565728.